Cannapharmarx Partners With ICAN To Expand Cannabis Distribution In Latin America
Cannapharmarx Partners With ICAN To Expand Cannabis Distribution In Latin America
Cannapharmarx Inc (OTCPK: CPMD) has entered into a multi-year supply agreement with ICAN Green S.A. de C.V., part of ICAN Investing Group LLC. This partnership aims to establish a robust distribution network across Latin America, with a keen focus on Mexico and Panama.
Cannapharmarx Inc.（場外交易代碼：CPMD）已與ICAN投資集團有限責任公司旗下的ICAN Green S.A. de C.V. 簽訂了爲期多年的供應協議。該夥伴關係旨在在拉丁美洲建立強大的分銷網絡，重點是墨西哥和巴拿馬。
CannaPharmaRx, recognized for its cutting-edge cannabis production facilities, will supply ICAN with a range of cannabis products. This agreement mandates ICAN to meet minimum annual purchase requirements, underscoring the deal's magnitude for both entities.
CannaPharmarX以其尖端的大麻生產設施而聞名，它將向ICAN提供一系列大麻產品。該協議要求ICAN滿足最低年度購買要求，這突顯了這兩家實體的交易規模。
ICAN, a pioneering force in the Latin American cannabis sector, specializes in the education, research, and development of cannabis-based medications. Notably, it stands as the first company to legally import THC API into Mexico, marking a historical milestone in the region's cannabis landscape.
ICAN是拉丁美洲大麻領域的先驅力量，專門從事大麻類藥物的教育、研究和開發。值得注意的是，它是第一家合法向墨西哥進口四氫大麻酚API的公司，這標誌着該地區大麻領域的歷史里程碑。
CEOs Comment On Partnership
首席執行官對夥伴關係的評論
Dean Medwid, CEO of CannaPharmaRx, expressed enthusiasm about the partnership, calling it a pivotal step towards the company's international expansion strategy. "By securing this strategic partnership with ICAN, we continue to evolve our systematic international expansion strategy that will create diversity of revenue and allow us to introduce our high-quality products to an expanding global audience."
CannaPharmarX首席執行官迪恩·梅德威德對這種合作表示了熱情，稱這是該公司邁向國際擴張戰略的關鍵一步。“通過確保與ICAN的戰略合作伙伴關係，我們將繼續發展我們的系統性國際擴張戰略，這將創造收入的多元化，並使我們能夠向越來越多的全球受衆介紹我們的高質量產品。”
Erick Ponce, CEO of ICAN, mirrored this sentiment, emphasizing the partnership's role in transforming healthcare in Latin America through innovative cannabis solutions. "Our collaboration with CannaPharmaRx marks a crucial advancement in our journey to revolutionize patient care with high-quality, research-driven cannabis products," Ponce remarked.
ICAN首席執行官埃裏克·龐塞反映了這一觀點，強調了該夥伴關係在通過創新的大麻解決方案改造拉丁美洲醫療保健方面的作用。龐塞說：“我們與CannaPharmarX的合作標誌着我們通過高質量、研究驅動的大麻產品徹底改變患者護理的旅程取得了關鍵進展。”
With a commitment to utilizing the latest technology in power generation, CannaPharmaRx aims to establish itself as a low-cost cannabis producer, contributing significantly to the industry's growth and accessibility in Latin America and beyond.
CannaPharmarx致力於利用最新的發電技術，旨在將自己確立爲低成本大麻生產商的地位，爲該行業在拉丁美洲及其他地區的增長和可及性做出重大貢獻。
CPMD Price Action
CPMD 價格走勢
CPMD's shares were trading at $0.013 per share at the time of this writing around 9:30 AM ET Tuesday.
在撰寫本文時，美國東部時間週二上午9點30分左右，CPMD的股票交易價格爲每股0.013美元。